Evidence map›Paper›PMID 38379935›Full record

ArticleMaterials today. Bio2024

Durable protective efficiency provide by mRNA vaccines require robust immune memory to antigens and weak immune memory to lipid nanoparticles.

Xueying Tang, Jiashuo Zhang, Dezhi Sui, Zihan Xu, Qiongfen Yang, Tianyu Wang, Xiaoya Li, Xinrong Liu, Yihui Deng, Yanzhi Song

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Decoding Undesirable Inflammatory Responses of Nucleic Acid-Delivering Lipid Nanoparticles.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Xueying TangCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.
Jiashuo ZhangCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.
Dezhi SuiCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.
Zihan XuCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.
Qiongfen YangCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.
Tianyu WangCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.
Xiaoya LiCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.
Xinrong LiuCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.
Yihui DengCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.
Yanzhi SongCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.
Shenyang Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Pegylated lipids in lipid nanoparticle (LNPs) vaccines have been found to cause acute hypersensitivity reactions in recipients, and generate

Indexed as

Immune memoryLipid nanoparticlesmRNA cancer vaccineSialic acidTumor immune cycle

Identifiers

PMID38379935
PMCPMC10877184
OpenAlexW4391691326

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.